AbbVie

NYSE

ABBV

paper.types.company

Rentabilité sur six mois: +1.17%
Rendement en dividendes: 3.3%
Secteur: Healthcare

Nouvelles Télégramme

CERE DEADLINE NOTICE: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Cerevel Therapeutics Holdings, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important June 3 Deadline in Securities Class Action - CERE

25 peut 22:32 CERE DEADLINE NOTICE: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Cerevel Therapeutics Holdings, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important June 3 Deadline in Securities Class Action - CERE

U.S. Pharmaceutical Imports Might Soon Face Tariffs: 3 Stocks That Could Tumble as a Result

24 peut 08:11 U.S. Pharmaceutical Imports Might Soon Face Tariffs: 3 Stocks That Could Tumble as a Result

ROSEN, LEADING INVESTOR COUNSEL, Encourages Cerevel Therapeutics Holdings, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - CERE

22 peut 20:54 ROSEN, LEADING INVESTOR COUNSEL, Encourages Cerevel Therapeutics Holdings, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - CERE

Pfizer Signs Experimental Drug Licensing Agreement With 3SBio

20 peut 10:28 Pfizer Signs Experimental Drug Licensing Agreement With 3SBio

ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Cerevel Therapeutics Holdings, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - CERE

20 peut 00:00 ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Cerevel Therapeutics Holdings, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - CERE

Cerevel Therapeutics Holdings, Inc. Investors: Please contact the Portnoy Law Firm to recover your losses. June 3, 2025 Deadline to file Lead Plaintiff Motion

19 peut 21:59 Cerevel Therapeutics Holdings, Inc. Investors: Please contact the Portnoy Law Firm to recover your losses. June 3, 2025 Deadline to file Lead Plaintiff Motion

PFE vs. MRK: Which Oncology Drug Giant is a Better Buy Now?

19 peut 12:29 PFE vs. MRK: Which Oncology Drug Giant is a Better Buy Now?

After FDA approval, first prescription eye drops to treat blurry near vision hit shelves

19 peut 03:59 After FDA approval, first prescription eye drops to treat blurry near vision hit shelves

Drugmakers raised prices by 6.6% on average early this year

19 peut 03:52 Drugmakers raised prices by 6.6% on average early this year

Biden pushes Congress to allow Medicare to negotiate drug prices

19 peut 03:05 Biden pushes Congress to allow Medicare to negotiate drug prices